NCT00231829View on ClinicalTrials.gov

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

PHASE2TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Uterine Cancer
Interventions
DRUG

Celecoxib

Trial Locations (1)

10461

Montefiore Medical Center, The Bronx

Sponsors

Collaborators (1)

Pharmacia
All Listed Sponsors
collaborator

Pharmacia

INDUSTRY

lead

Mark H. Einstein

OTHER

NCT00231829 - A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | Biotech Hunter | Biotech Hunter